OLTMANS CURTIS GALE (SVP, General Counsel) sold 25.2% of their position (3.45K shares) of FULCRUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $44.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/17/2025ACC: 0001193125-25-322740
Officer· SVP, General Counsel
Since Nov 2020
-3.45K
Net shares
Net seller
$44.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.45K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.45K
Price / share
$12.92
Trade value
$44.60K
% of position
25.2%
12/15/2025
13.70K→10.25K
Total
Net shares
−3.45K
Net value
-$44.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | S · Sale | −3.45K | $12.92 | $44.60K | 25.2% | 13.70K | 10.25K |
| Total | −3.45K | -$44.60K | ||||||
Derivative Transactions0
No derivative transactions reported